Adele Rowley
Chief Scientific Officer Mironid
Seminars
Wednesday 19th August 2026
Leveraging Signaling Networks to Identify & Therapeutically Target Disease-Relevant Pathways in ADPKD
11:00 am
- Identifying and validating disease-driving signaling pathways across rare and genetic kidney diseases
- Evaluating strategies to therapeutically modulate dysregulated pathways, including inhibition, activation, and allosteric regulation
- Understanding how targeting different points in a signaling cascade influences disease progression and treatment outcomes
